FPF 1070 · Cerebrolysate · Neuropeptide Preparation
A brain-derived neuropeptide mixture studied for stroke recovery, dementia, and cognitive protection
Typical Dose
5–10 mL per session (IV or IM)
Route
Intravenous
Frequency
Daily for 10–20 days (course-based treatment)
Cycle
10–20 day course, repeated 2–4 times per year

Cerebrolysin is unlike most peptides on this site. It is not a single synthetic compound but a carefully prepared mixture of small peptides and amino acids derived from porcine (pig) brain tissue. Think of it as a concentrated extract of the brain's own repair signals. The manufacturing process breaks down brain proteins into tiny fragments that are small enough to cross the blood-brain barrier — the protective wall that keeps most substances out of the brain. Once inside, these fragments mimic the actions of the brain's own growth factors, the proteins that keep neurons alive, growing, and connected. It has been used clinically in Europe and Asia for decades and is one of the most studied neuroprotective agents in the world, though it remains unapproved in the United States.
Cerebrolysin works through several pathways at once. Its peptide fragments mimic the actions of natural neurotrophic factors — proteins like NGF and BDNF that your brain normally produces to keep neurons healthy and growing. Think of neurotrophic factors as fertilizer for your brain cells. Cerebrolysin also protects neurons from the damage caused by reduced blood flow (ischemia), overstimulation by neurotransmitters (excitotoxicity), and oxidative stress — three of the main ways neurons die after a stroke or injury. On top of that, it helps the brain use glucose more efficiently, which is important because the brain runs almost entirely on glucose for energy.
Typical Dose
5–10 mL per session (IV or IM)
Dose Range
5–30 mL per session depending on condition
Frequency
Daily for 10–20 days (course-based treatment)
Route
Intravenous (IV) infusion or intramuscular (IM) injection
Cycle Length
10–20 day course, repeated 2–4 times per year
CLINICAL NOTES
Cerebrolysin is typically administered as a course rather than ongoing daily use. IV infusion is preferred for acute conditions (stroke, TBI) and provides faster onset. IM injection is used for maintenance and outpatient protocols. Dosing varies widely by condition: stroke protocols often use 30 mL/day IV for 10–21 days; cognitive enhancement protocols typically use 5–10 mL IM for 10 days. Always administered under medical supervision.
IMPORTANT DISCLAIMER
This information is for educational purposes only. Always consult a qualified healthcare provider before starting any peptide protocol. Individual responses vary and medical supervision is recommended.
Real experiences from the Peptide Insights community
Real experiences from real people help others make informed decisions. Share what worked, what didn't, and what you wish you'd known before starting.
Free account required. Your review helps the Peptide Insights community.
Be the first to share your experience. Your insight could help someone else decide if Cerebrolysin is right for them.
Sign In to Be the FirstGet our free 32-page Beginner's Guide — plain-language breakdowns of the top peptides, dosing essentials, and safety basics.
32-page PDF, instant download
Compounds often researched alongside Cerebrolysin
A neuropeptide for enhanced focus, memory, and brain protection
An anxiolytic nootropic peptide for calm focus and stress relief
Mitochondrial electron carrier studied for cognitive enhancement and neuroprotection
The master coenzyme for cellular energy, DNA repair, and sirtuin-driven longevity